[1]
|
Shih, C.M., Chen, C.C., Chu, C.K., et al. (2020) The Roles of Lipoprotein in Psoriasis. International Journal of Mo-lecular Sciences, 21, Article No. 859. https://doi.org/10.3390/ijms21030859
|
[2]
|
Honma, M. and Nozaki, H. (2021) Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity. Journal of Clinical Medicine, 10, Article No. 3199. https://doi.org/10.3390/jcm10153199
|
[3]
|
Imafuku, S., Kanai, Y., Murotani, K., et al. (2021) Utility of the Dermatology Life Quality Index at Initiation or Switching of Biologics in Real-Life Japanese Patients with Plaque Psoriasis: Results from the ProLOGUE Study. Journal of Dermatological Science, 101, 185-193. https://doi.org/10.1016/j.jdermsci.2021.01.002
|
[4]
|
Meneguin, S., de Godoy, N.A., Pollo, C.F., et al. (2020) Quality of Life of Patients Living with Psoriasis: A Qualitative Study. BMC Dermatology, 20, Article No. 22.
|
[5]
|
晋红中, 吴超. 银屑病的共病:研究现状与前景[J]. 实用皮肤病学杂志, 2020, 13(4): 193-197.
|
[6]
|
Gisondi, P., Fostini, A.C., Fossà, I., Girolomoni, G. and Targher, G. (2018) Psoriasis and the Metabolic Syndrome. Clinics in Der-matology, 36, 21-28. https://doi.org/10.1016/j.clindermatol.2017.09.005
|
[7]
|
Zeng, C., Wen, B., Hou, G., Lei, L., Mei, Z., Jia, X., Chen, X., Zhu, W., Li, J., Kuang, Y., Zeng, W., Su, J., Liu, S., Peng, C. and Chen, X. (2017) Lipidomics Profiling Reveals the Role of Glycerophospholipid Metabolism in Psoriasis. Gigascience, 6, 1-11. https://doi.org/10.1093/gigascience/gix087
|
[8]
|
Nowowiejska, J., Baran, A. and Flisiak, I. (2021) Aberrations in Lipid Expression and Metabolism in Psoriasis. International Journal of Molecular Sciences, 22, Article No. 6561. https://doi.org/10.3390/ijms22126561
|
[9]
|
李雪, 解欣然, 蒙玉娇, 等. 银屑病与胰岛素抵抗[J]. 环球中医药, 2019, 12(6): 972-978.
|
[10]
|
Wen, S., Liu, C.Y., Li, Y.Y., et al. (2021) Psoriasis Exacerbates the State of Insulin Re-sistance in Patients with Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity, 14, 2389-2397. https://doi.org/10.2147/DMSO.S312420
|
[11]
|
Polic, M.V., Miskulin, M., Smolic, M., et al. (2018) Psoriasis Se-verity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome. International Journal of Environ-mental Research and Public Health, 15, Article No. 1486. https://doi.org/10.3390/ijerph15071486
|
[12]
|
Brazzelli, V., Maffioli, P., Bolcato, V., et al. (2021) Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Re-sistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers. Frontiers in Medicine, 8, Article ID: 605691. https://doi.org/10.3389/fmed.2021.605691
|
[13]
|
Hiebert, P. and Werner, S. (2018) Targeting Metabolism to Treat Psoriasis. Nature Medicine, 24, 537-539.
https://doi.org/10.1038/s41591-018-0027-5
|
[14]
|
Hodeib, A.A., Neinaa, Y.M., Zakaria, S.S., et al. (2018) Glucose Transporter-1 (GLUT-1) Expression in Psoriasis: Correlation with Disease Severity. International Journal of Dermatology, 57, 943-951.
https://doi.org/10.1111/ijd.14037
|
[15]
|
Zhao, X.C., Xing, J.X., Li, J.Q., et al. (2021) Dysregulated Dermal Mesenchymal Stem Cell Proliferation and Differentiation Interfered by Glucose Metabolism in Psoriasis. International Journal of Stem Cells, 14, 85-93.
https://doi.org/10.15283/ijsc20073
|
[16]
|
Li, J., Xing, J., Lu, F., Chang, W., et al. (2020) Psoriatic Dermal-Derived Mesenchymal Stem Cells Reduce Keratinocyte Junctions, and Increase Glycolysis. Acta Dermato-Venereologica, 100, adv00122.
|
[17]
|
Sitter, B., Johnsson, M.K., Halgunset, J., et al. (2013) Metabolic Changes in Psoriatic Skin under Topical Corticosteroid Treatment. BMC Dermatology, 13, Article No. 8. https://doi.org/10.1186/1471-5945-13-8
|
[18]
|
Friis, N.U., Hoffmann, N., Gyldenløve, M., et al. (2019) Glucose Metabolism in Patients with Psoriasis. British Journal of Dermatology, 180, 264-271. https://doi.org/10.1111/bjd.17349
|
[19]
|
Gyldenløve, M., Vilsbøll, T., Holst, J.J., et al. (2016) Disturbed Post-prandial Glucose Metabolism and Gut Hormone Responses in Non-Diabetic Patients with Psoriasis. British Journal of Dermatology, 175, 1085-1088.
https://doi.org/10.1111/bjd.13789
|
[20]
|
Sorokin, A.V., Domenichiello, A.F., Dey, A.K., et al. (2018) Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood. Journal of Investigative Dermatology, 138, 1518-1528. https://doi.org/10.1016/j.jid.2018.02.003
|
[21]
|
Duvetorp, A., Olsen, R.S., Nyström, H., et al. (2017) Expression of Low-Density Lipoprotein-Related Receptors 5 and 6 (LRP5/6) in Psoriasis Skin. Experimental Dermatology, 26, 1033-1038. https://doi.org/10.1111/exd.13362
|
[22]
|
Shih, C.M., Huang, C.Y., Wang, K.H., et al. (2018) Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Ex-pression in Vivo and in Vitro. International Journal of Molecular Sciences, 19, Article No. 2610. https://doi.org/10.3390/ijms19092610
|
[23]
|
Dey, A.K., Gaddipati, R., Elnabawi, Y.A., et al. (2020) Association between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis. JAMA Dermatology, 156, 151-157.
https://doi.org/10.1001/jamadermatol.2019.3595
|
[24]
|
Sertznig, P., Seifert, M., Tilgen, W. and Reichrath, J. (2008) Peroxisome Proliferator-Activated Receptors (PPARs) and the Human Skin: Importance of PPARs in Skin Physiology and Dermatologic Diseases. American Journal of Clinical Dermatology, 9, 15-31. https://doi.org/10.2165/00128071-200809010-00002
|
[25]
|
Gao, Y.L., Yi, X.M. and Ding, Y.F. (2017) Combined Transcriptomic Analysis Revealed AKR1B10 Played an Important Role in Psoriasis through the Dysregulated Lipid Pathway and Overproliferation of Keratinocyte. BioMed Research International, 2017, Article ID: 8717369. https://doi.org/10.1155/2017/8717369
|
[26]
|
Baran, A., Kiluk, P., Myśliwiec, H., et al. (2017) The Role of Lipids in Psoriasis. Dermatology Review, 104, 619-635.
https://doi.org/10.5114/dr.2017.71834
|
[27]
|
Pietrzak, A., Chabros, P., Grywalska, E., et al. (2019) Serum Lipid Metabolism in Psoriasis and Psoriatic Arthritis—An Update. Archives of Medical Science, 15, 369-375.
|
[28]
|
Varshney, P., Narasimhan, A., Mittal, S., et al. (2016) Transcriptome Profiling Unveils the Role of Cholesterol in IL-17A Signaling in Psoriasis. Scientific Reports, 6, Article No. 19295. https://doi.org/10.1038/srep19295
|
[29]
|
田蔚蔚, 刘伟军, 赵静, 等. 银屑病患者脂肪因子水平及其与代谢性疾病的相关性研究[J]. 江西医药, 2021, 56(2): 173-177.
|
[30]
|
Blumenberg, M. (2013) Skinomics: Past, Present and Future for Diagnostic Microarray Studies in Dermatology. Expert Review of Molecular Diagnostics, 13, 885-894. https://doi.org/10.1586/14737159.2013.846827
|
[31]
|
Lundberg, K.C., Fritz, Y., Johnston, A., et al. (2015) Pro-teomics of Skin Proteins in Psoriasis: From Discovery and Verification in a Mouse Model to Confirmation in Humans. Molecular & Cellular Proteomics, 14, 109-119.
https://doi.org/10.1074/mcp.M114.042242
|
[32]
|
Bansal, P., Gaur, S.N. and Arora, N. (2016) Lysophosphatidylcholine Plays Critical Role in Allergic Airway Disease Manifestation. Scientific Reports, 6, Article No. 27430. https://doi.org/10.1038/srep27430
|
[33]
|
Lian, N., Shi, L.Q., Hao, Z.M., et al. (2020) Research Progress and Perspective in Metabolism and Metabolomics of Psoriasis. Chinese Medical Journal, 133, 2976-2986. https://doi.org/10.1097/CM9.0000000000001242
|
[34]
|
Awada, R., Saulnier-Blache, J.S., Grès, S., et al. (2014) Autotaxin Downregulates LPS-Induced Microglia Activation and Pro-Inflammatory Cytokines Production. Journal of Cellular Biochemistry, 115, 2123-2132.
https://doi.org/10.1002/jcb.24889
|
[35]
|
Kovács, D., Fazekas, F., Oláh, A., et al. (2020) Adipokines in the Skin and in Dermatological Diseases. International Journal of Molecular Sciences, 21, Article No. 9048. https://doi.org/10.3390/ijms21239048
|
[36]
|
Kong, Y., Zhang, S., Wu, R., Su, X., et al. (2019) New Insights into Different Adipokines in Linking the Pathophysiology of Obesity and Psoriasis. Lipids in Health and Disease, 18, Article No. 171.
https://doi.org/10.1186/s12944-019-1115-3
|
[37]
|
Wu, C.Y., Shieh, J.J., Shen, J.L., et al. (2015) Association be-tween Antidiabetic Drugs and Psoriasis Risk in Diabetic Patients: Results from a Nationwide Nested Case-Control Study in Taiwan. Journal of the American Academy of Dermatology, 72, 123-130. https://doi.org/10.1016/j.jaad.2014.08.042
|
[38]
|
Chang, G., Chen, B. and Zhang, L. (2021) Efficacy of GLP-1rA, Liraglutide, in Plaque Psoriasis Treatment with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Cohort and Before-After Studies. Journal of Dermatological Treatment, 3, 1-10. https://doi.org/10.1080/09546634.2021.1882658
|
[39]
|
Xu, X., Lin, L., Chen, P., et al. (2019) Treatment with Liraglutide, a Glucagon-Like Peptide-1 Analogue, Improves Effectively the Skin Lesions of Psoriasis Patients with Type 2 Diabetes: A Prospective Cohort Study. Diabetes Research and Clinical Practice, 150, 167-173. https://doi.org/10.1016/j.diabres.2019.03.002
|
[40]
|
Lin, L., Xu, X., Yu, Y., et al. (2020) Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Therapy for Psoriasis Patients with Type 2 Diabetes: A Randomized-Controlled Trial. Journal of Dermatological Treatment, 1-7.
https://doi.org/10.1080/09546634.2020.1826392
|
[41]
|
Almeida, S.O. and Budoff, M. (2019) Effect of Statins on Atherosclerotic Plaque. Trends in Cardiovascular Medicine, 29, 451-455. https://doi.org/10.1016/j.tcm.2019.01.001
|
[42]
|
Oesterle, A., Laufs, U. and Liao, J.K. (2017) Pleiotropic Effects of Statins on the Cardiovascular System. Circulation Research, 120, 229-243.
|
[43]
|
Trong, H.N., Tat, T.N., Anh, T.T.N., et al. (2019) Efficacy of Adding Oral Simvastatin to Topical Therapy for Treatment of Psoriasis: The Vietnamese Experience. Open Access Macedonian Journal of Medical Sciences, 7, 237-242.
|
[44]
|
宋青蔓. 联合应用辛伐他汀在局部药物治疗寻常型银屑病中的效果[J]. 实用中西医结合临床, 2020, 20(15): 96-97.
|
[45]
|
Nowowiejska, J., Baran, A. and Flisiak, I. (2020) Psoriasis and Cardiometabolic Disorders. Dermatology Review, 107, 508-520.
|
[46]
|
Amoruso, G.F., Nisticò, S.P., Iannone, L., et al. (2021) Ixekizumab May Improve Renal Function in Psoriasis. Healthcare, 9, Article No. 543. https://doi.org/10.3390/healthcare9050543
|
[47]
|
Botelho, K.P., Pontes, M.A.A., Rodrigues, C.E.M., et al. (2020) Prevalence of Metabolic Syndrome among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study. Metabolic Syndrome and Related Disorders, 18, 154-160. https://doi.org/10.1089/met.2019.0092
|